Yong‐Jin Im

485 total citations
33 papers, 279 citations indexed

About

Yong‐Jin Im is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yong‐Jin Im has authored 33 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yong‐Jin Im's work include Thin-Film Transistor Technologies (4 papers), ZnO doping and properties (3 papers) and Nausea and vomiting management (2 papers). Yong‐Jin Im is often cited by papers focused on Thin-Film Transistor Technologies (4 papers), ZnO doping and properties (3 papers) and Nausea and vomiting management (2 papers). Yong‐Jin Im collaborates with scholars based in South Korea, United States and Belgium. Yong‐Jin Im's co-authors include Min‐Gul Kim, Yunjeong Kim, Ji‐Young Jeon, Soo‐Wan Chae, Tae Sun Park, Song‐Hee Han, Young‐Chul Chung, Moonsuk Yi, Chan Hee Park and Sun‐Young Lee and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Pharmacology & Therapeutics.

In The Last Decade

Yong‐Jin Im

32 papers receiving 264 citations

Peers

Countries citing papers authored by Yong‐Jin Im

Since Specialization

Citations

This map shows the geographic impact of Yong‐Jin Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Jin Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Jin Im more than expected).

Fields of papers citing papers by Yong‐Jin Im

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Jin Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Jin Im. The network helps show where Yong‐Jin Im may publish in the future.

Co-authorship network of co-authors of Yong‐Jin Im

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Jin Im. A scholar is included among the top collaborators of Yong‐Jin Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Jin Im. Yong‐Jin Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of an External Control Arm Using Electronic Health Record‐Based Real‐World Data to Evaluate the Efficacy of COVID‐19 Treatment 2023 ·Clinical Pharmacology & Therapeutics ·Ji‐Young Jeon, (unknown), (unknown), Yong‐Jin Im, (unknown), (unknown), Ki Tae Kwon, Jeong‐Hwan Hwang, Jong Seung Kim, (unknown), (unknown)	2
2	Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study 2023 ·Frontiers in Medicine ·Min‐Gul Kim, Yong‐Jin Im, Jong‐Hwan Lee, (unknown), (unknown), Jong Seung Kim	7
3	Long-term taxonomic and functional stability of the gut microbiome from human fecal samples 2023 ·Scientific Reports ·Jae Hyun Kim, Ji‐Young Jeon, Yong‐Jin Im, Na Young Ha, Jeon-Kyung Kim, (unknown), Min‐Gul Kim	14
4	Treatment outcomes of oral doxycycline versus intravenous azithromycin in adults hospitalized with scrub typhus: A retrospective study using inverse probability treatment weighting (IPTW) propensity analysis 2022 ·Travel Medicine and Infectious Disease ·Jeong‐Hwan Hwang, (unknown), (unknown), Yong‐Jin Im, (unknown), (unknown), (unknown), (unknown), Jong Seung Kim, Min‐Gul Kim	4
5	Occlusion type and posterior communicating artery patency may predict favorable outcome after endovascular thrombectomy in selective basilar top occlusion 2022 ·Frontiers in Neurology ·Jung Soo Park, Yong‐Jin Im, Byoung‐Soo Shin, Hyun Goo Kang	1
6	Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019 2021 ·Journal of Korean Medical Science ·Kyung Ae Lee, Heung Yong Jin, (unknown), Yong‐Jin Im, (unknown), Tae Sun Park	17
7	A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study 2018 ·Cancer Research and Treatment ·Soyeon Jeon, Hye Sook Han, Woo Kyun Bae, (unknown), Hyeok Shim, Sang‐Cheol Lee, Se‐Il Go, Hwan‐Jung Yun, Yong‐Jin Im, Eun‐Kee Song	16
8	An Assessment of the Pharmacokinetics of a Sustained-release Formulation of a Tramadol/Acetaminophen Combination in Healthy Subjects 2015 ·Clinical Therapeutics ·Yong‐Jin Im, Ji‐Young Jeon, (unknown), Yunjeong Kim, (unknown), (unknown), Dae‐Hee Shin, Soo‐Wan Chae, Min‐Gul Kim	5
9	Effects of Double Active Layer and Acetic Acid Stabilizer on the Electrical Properties of a Solution-Processed Zinc Tin Oxide Thin-Film Transistor 2015 ·Journal of Nanoscience and Nanotechnology ·(unknown), (unknown), (unknown), Yong‐Jin Im, Chan Hee Park, Moonsuk Yi	2
10	Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults 2014 ·Clinical Therapeutics ·Ji‐Young Jeon, Sun Young Lee, Yong‐Jin Im, (unknown), Yunjeong Kim, Tae Sun Park, Soo‐Wan Chae, Jae‐Won Lee, (unknown), Tae Won Lee, Min‐Gul Kim	5
11	Pharmacokinetic Comparison Study of a Combination Containing 500 mg of Naproxen and 20 mg of Esomeprazole: A Randomized, Single-dose, 2-way Crossover, Open-label Study in Healthy Korean Men 2014 ·Clinical Therapeutics ·(unknown), Ji‐Young Jeon, (unknown), (unknown), (unknown), Yong‐Jin Im, (unknown), (unknown), Yunjeong Kim, Sun Young Lee, Min‐Gul Kim	8
12	Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects 2014 ·Clinical Drug Investigation ·(unknown), Ji‐Young Jeon, Yong‐Jin Im, Yunjeong Kim, Eun‐Kee Song, (unknown), (unknown), Min‐Gul Kim	8
13	The Validities and Efficiencies of Korean ADHD Rating Scale and Korean Child Behavior Checklist for Screening Children with ADHD in the Community 2014 ·Psychiatry Investigation ·Jong‐Il Park, (unknown), (unknown), Young‐Eun Jung, Tae Won Park, (unknown), Yong‐Jin Im, Jong-Chul Yang, Young‐Chul Chung, Sang‐Keun Chung	24
14	Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application 2013 ·Journal of Ginseng Research ·Jung Soo Kim, Yunjeong Kim, Song‐Hee Han, Ji‐Young Jeon, (unknown), Yong‐Jin Im, Jung Hyun Kim, Sun‐Young Lee, Soo‐Wan Chae, Min‐Gul Kim	30
15	Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response 2013 ·Gut and Liver ·(unknown), In Hee Kim, (unknown), (unknown), (unknown), (unknown), Seok Lee, Seong‐Hun Kim, Sang Wook Kim, Yong‐Jin Im	13
16	Confirmation of Schizandrin as a Marker Compound in Jangsu Omija Powder 2013 ·Journal of the Korean Society of Food Science and Nutrition ·Yunjeong Kim, (unknown), Song‐Hee Han, Ji‐Young Jeon, (unknown), Yong‐Jin Im, Sun‐Young Lee, Soo‐Wan Chae, Min‐Gul Kim	7
17	Validation of the Korean version of the Eppendorf Schizophrenia Inventory as a screening measure to detect adolescents at ultra‐high risk for psychosis 2012 ·Early Intervention in Psychiatry ·Young‐Chul Chung, (unknown), Yong‐Jin Im, Sung‐Wan Kim, In-Hee Cho, Young Moo Lee, Jun Soo Kwon	19
18	Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers 2012 ·Drug Development and Industrial Pharmacy ·Ji‐Young Jeon, Yong‐Jin Im, Yunjeong Kim, (unknown), (unknown), Dae‐Hee Shin, (unknown), (unknown), (unknown), Byung‐Hoon Lee, Yoon‐Ho Choi, (unknown), (unknown), Soo‐Wan Chae, Min‐Gul Kim	11
19	Method Development of Ellagic Acid as Marker Compound for Standardization of Gochang Bokbunja (Rubus coreanus Miquel) as Functional Ingredient 2012 ·Journal of the Korean Society of Food Science and Nutrition ·Yunjeong Kim, Song‐Hee Han, (unknown), (unknown), Yong‐Jin Im, Soo‐Wan Chae, Min‐Gul Kim	11
20	Reactive Dyeing in Immiscible Two-phase System of Water/Organic Solvent(II) - The Dyeing of Silk with C. I. Reactive Blue 203 - 2001 ·Textile Coloration and Finishing ·(unknown), Mi-Gyeong Kim, Yong‐Jin Im, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact